anmelden
AstraZeneca Aktie
141,75
EUR
+1,20
EUR
+0,85
%
141,45
EUR
+1,35
EUR
+0,96
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 220,05 Mrd. EUR
KGV 27,55 Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Werbung
AstraZeneca Aktie Analyse
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.10.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.10.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.09.18 | AstraZeneca Neutral | UBS AG | |
| 24.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.09.18 | AstraZeneca Outperform | BNP PARIBAS | |
| 07.09.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 31.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 16.08.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.08.18 | AstraZeneca Reduce | HSBC | |
| 10.08.18 | AstraZeneca overweight | Barclays Capital | |
| 07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | AstraZeneca Neutral | UBS AG | |
| 30.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 27.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
Werbung
Werbung
